FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3034965161> ?p ?o ?g. }

• W3034965161 endingPage "922" @default.
• W3034965161 startingPage "914" @default.
• W3034965161 abstract "BackgroundEarly reports on patients with cancer and COVID-19 have suggested a high mortality rate compared with the general population. Patients with thoracic malignancies are thought to be particularly susceptible to COVID-19 given their older age, smoking habits, and pre-existing cardiopulmonary comorbidities, in addition to cancer treatments. We aimed to study the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on patients with thoracic malignancies.MethodsThe Thoracic Cancers International COVID-19 Collaboration (TERAVOLT) registry is a multicentre observational study composed of a cross-sectional component and a longitudinal cohort component. Eligibility criteria were the presence of any thoracic cancer (non-small-cell lung cancer [NSCLC], small-cell lung cancer, mesothelioma, thymic epithelial tumours, and other pulmonary neuroendocrine neoplasms) and a COVID-19 diagnosis, either laboratory confirmed with RT-PCR, suspected with symptoms and contacts, or radiologically suspected cases with lung imaging features consistent with COVID-19 pneumonia and symptoms. Patients of any age, sex, histology, or stage were considered eligible, including those in active treatment and clinical follow-up. Clinical data were extracted from medical records of consecutive patients from Jan 1, 2020, and will be collected until the end of pandemic declared by WHO. Data on demographics, oncological history and comorbidities, COVID-19 diagnosis, and course of illness and clinical outcomes were collected. Associations between demographic or clinical characteristics and outcomes were measured with odds ratios (ORs) with 95% CIs using univariable and multivariable logistic regression, with sex, age, smoking status, hypertension, and chronic obstructive pulmonary disease included in multivariable analysis. This is a preliminary analysis of the first 200 patients. The registry continues to accept new sites and patient data.FindingsBetween March 26 and April 12, 2020, 200 patients with COVID-19 and thoracic cancers from eight countries were identified and included in the TERAVOLT registry; median age was 68·0 years (61·8–75·0) and the majority had an Eastern Cooperative Oncology Group performance status of 0–1 (142 [72%] of 196 patients), were current or former smokers (159 [81%] of 196), had non-small-cell lung cancer (151 [76%] of 200), and were on therapy at the time of COVID-19 diagnosis (147 [74%] of 199), with 112 (57%) of 197 on first-line treatment. 152 (76%) patients were hospitalised and 66 (33%) died. 13 (10%) of 134 patients who met criteria for ICU admission were admitted to ICU; the remaining 121 were hospitalised, but were not admitted to ICU. Univariable analyses revealed that being older than 65 years (OR 1·88, 95% 1·00–3·62), being a current or former smoker (4·24, 1·70–12·95), receiving treatment with chemotherapy alone (2·54, 1·09–6·11), and the presence of any comorbidities (2·65, 1·09–7·46) were associated with increased risk of death. However, in multivariable analysis, only smoking history (OR 3·18, 95% CI 1·11–9·06) was associated with increased risk of death.InterpretationWith an ongoing global pandemic of COVID-19, our data suggest high mortality and low admission to intensive care in patients with thoracic cancer. Whether mortality could be reduced with treatment in intensive care remains to be determined. With improved cancer therapeutic options, access to intensive care should be discussed in a multidisciplinary setting based on cancer specific mortality and patients' preference.FundingNone." @default.
• W3034965161 created "2020-06-19" @default.
• W3034965161 creator A5003892829 @default.
• W3034965161 creator A5005147875 @default.
• W3034965161 creator A5009203974 @default.
• W3034965161 creator A5009968141 @default.
• W3034965161 creator A5010972450 @default.
• W3034965161 creator A5011205244 @default.
• W3034965161 creator A5012939000 @default.
• W3034965161 creator A5013144277 @default.
• W3034965161 creator A5013768705 @default.
• W3034965161 creator A5017416242 @default.
• W3034965161 creator A5017516824 @default.
• W3034965161 creator A5019053015 @default.
• W3034965161 creator A5028155080 @default.
• W3034965161 creator A5030465858 @default.
• W3034965161 creator A5032162127 @default.
• W3034965161 creator A5032477448 @default.
• W3034965161 creator A5033351253 @default.
• W3034965161 creator A5035471408 @default.
• W3034965161 creator A5035640724 @default.
• W3034965161 creator A5035940602 @default.
• W3034965161 creator A5038556220 @default.
• W3034965161 creator A5040884103 @default.
• W3034965161 creator A5043871151 @default.
• W3034965161 creator A5047822022 @default.
• W3034965161 creator A5049683414 @default.
• W3034965161 creator A5050766137 @default.
• W3034965161 creator A5053400405 @default.
• W3034965161 creator A5054299347 @default.
• W3034965161 creator A5055246540 @default.
• W3034965161 creator A5056367409 @default.
• W3034965161 creator A5059222814 @default.
• W3034965161 creator A5060954139 @default.
• W3034965161 creator A5062894702 @default.
• W3034965161 creator A5063300526 @default.
• W3034965161 creator A5068767434 @default.
• W3034965161 creator A5071783009 @default.
• W3034965161 creator A5075392197 @default.
• W3034965161 creator A5075642945 @default.
• W3034965161 creator A5078197901 @default.
• W3034965161 creator A5078402710 @default.
• W3034965161 creator A5078917021 @default.
• W3034965161 creator A5082798685 @default.
• W3034965161 creator A5083786421 @default.
• W3034965161 creator A5086247944 @default.
• W3034965161 creator A5086528283 @default.
• W3034965161 creator A5087836238 @default.
• W3034965161 creator A5089022719 @default.
• W3034965161 creator A5090324173 @default.
• W3034965161 creator A5091509029 @default.
• W3034965161 date "2020-07-01" @default.
• W3034965161 modified "2023-10-18" @default.
• W3034965161 title "COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study" @default.
• W3034965161 cites W2996257414 @default.
• W3034965161 cites W2999417355 @default.
• W3034965161 cites W3001118548 @default.
• W3034965161 cites W3002108456 @default.
• W3034965161 cites W3006355661 @default.
• W3034965161 cites W3007298159 @default.
• W3034965161 cites W3008827533 @default.
• W3034965161 cites W3009885589 @default.
• W3034965161 cites W3010004613 @default.
• W3034965161 cites W3012696018 @default.
• W3034965161 cites W3012789146 @default.
• W3034965161 cites W3012860910 @default.
• W3034965161 cites W3013894953 @default.
• W3034965161 cites W3014080169 @default.
• W3034965161 cites W3014153414 @default.
• W3034965161 cites W3014294089 @default.
• W3034965161 cites W3015401256 @default.
• W3034965161 cites W3015988827 @default.
• W3034965161 cites W3024270013 @default.
• W3034965161 cites W3165656738 @default.
• W3034965161 doi "https://doi.org/10.1016/s1470-2045(20)30314-4" @default.
• W3034965161 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7292610" @default.
• W3034965161 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32539942" @default.
• W3034965161 hasPublicationYear "2020" @default.
• W3034965161 type Work @default.
• W3034965161 sameAs 3034965161 @default.
• W3034965161 citedByCount "458" @default.
• W3034965161 countsByYear W30349651612020 @default.
• W3034965161 countsByYear W30349651612021 @default.
• W3034965161 countsByYear W30349651612022 @default.
• W3034965161 countsByYear W30349651612023 @default.
• W3034965161 crossrefType "journal-article" @default.
• W3034965161 hasAuthorship W3034965161A5003892829 @default.
• W3034965161 hasAuthorship W3034965161A5005147875 @default.
• W3034965161 hasAuthorship W3034965161A5009203974 @default.
• W3034965161 hasAuthorship W3034965161A5009968141 @default.
• W3034965161 hasAuthorship W3034965161A5010972450 @default.
• W3034965161 hasAuthorship W3034965161A5011205244 @default.
• W3034965161 hasAuthorship W3034965161A5012939000 @default.
• W3034965161 hasAuthorship W3034965161A5013144277 @default.
• W3034965161 hasAuthorship W3034965161A5013768705 @default.
• W3034965161 hasAuthorship W3034965161A5017416242 @default.
• W3034965161 hasAuthorship W3034965161A5017516824 @default.
• W3034965161 hasAuthorship W3034965161A5019053015 @default.

• next